Alphabet Inc. Class C Capital Stock vs. SIENNA BIOPHARMACEUTICALS
GOOG
Alphabet Inc. Class C Capital Stock
$353.47 -0.88%
VS SNNAQSIENNA BIOPHARMACEUTICALS
$0.00 +0.00%
Alphabet Inc. Class C Capital Stock and SIENNA BIOPHARMACEUTICALS are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| GOOG | SNNAQ | |
|---|---|---|
| Market Cap | $4.32 trillion | — |
| Revenue (TTM) | $445.87 billion | — |
| Net Income (TTM) | $244.21 billion | — |
GOOG and SNNAQ split the size & scale factors evenly.
Valuation
| GOOG | SNNAQ | |
|---|---|---|
| P/E Ratio | 17.74 | — |
| Price / Book | 6.75 | — |
| Price / Sales | 9.70 | — |
GOOG and SNNAQ split the valuation factors evenly.
Profitability
| GOOG | SNNAQ | |
|---|---|---|
| Net Margin | 54.77% | — |
| Return on Equity | 38.13% | — |
GOOG and SNNAQ split the profitability factors evenly.
Dividend
| GOOG | SNNAQ | |
|---|---|---|
| Dividend Yield | 0.25% | — |
| Payout Ratio | 4.42 | — |
GOOG and SNNAQ split the dividend factors evenly.
Risk & Sentiment
| GOOG | SNNAQ | |
|---|---|---|
| Short Interest | 0.07% | — |
GOOG and SNNAQ split the risk & sentiment factors evenly.
Dig deeper: GOOG overview, GOOG financials, SNNAQ overview, SNNAQ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.